Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.6500 (3.84%) ($8.3300 - $8.7400) on Tue. Apr. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.23% (three month average) | RSI | 55 | Latest Price | $8.6500(3.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(4%) VXX(3%) BLOK(2%) IBB(2%) TBT(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.615% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.615% (StdDev 3.23%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
5 Day Moving Average | $8.16(6%) | 10 Day Moving Average | $7.92(9.22%) | 20 Day Moving Average | $8.01(7.99%) | To recent high | -11% | To recent low | 17.2% | Market Cap | $1.526b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |